Vectura

Vectura is a specialist inhalation CDMO that provides innovative inhaled drug delivery solutions which enable customers to bring their medicines to market. With differentiated proprietary technology and pharmaceutical development expertise, Vectura has device, formulation and development capabilities for delivering a broad range of complex inhaled therapies. Vectura has 13 inhaled and 11 non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development.

The company was founded in 1997, with its origins in the University of Bath (UK). The company has made several significant acquisitions in the respiratory space, including Innovata plc in 2007 and Activaero in 2014, and in 2016 it merged with Skyepharma, retaining the name Vectura.

What's this?